Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121136663 | 12113666 | 3 | F | 20160611 | 20160624 | 20160225 | 20160704 | EXP | PHHY2016ZA022852 | NOVARTIS | 59.86 | YR | M | Y | 0.00000 | 20160704 | CN | ZA | ZA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121136663 | 12113666 | 1 | PS | GILENYA | FINGOLIMOD HYDROCHLORIDE | 1 | Oral | 0.5 MG, UNK | 22527 | .5 | MG | CAPSULE | |||||||
| 121136663 | 12113666 | 2 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 121136663 | 12113666 | 3 | C | TRAMCET | ACETAMINOPHENTRAMADOL | 1 | Unknown | U | 0 | ||||||||||
| 121136663 | 12113666 | 4 | C | STILNOX | ZOLPIDEM TARTRATE | 1 | Unknown | U | 0 | ||||||||||
| 121136663 | 12113666 | 5 | C | CYMGEN | DULOXETINE HYDROCHLORIDE | 1 | Oral | 120 MG, UNK | 0 | 120 | MG | ||||||||
| 121136663 | 12113666 | 6 | C | CYMGEN | DULOXETINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 121136663 | 12113666 | 7 | C | CEREBREX | CALCIUM GLYCEROPHOSPHATECALCIUM PHOSPHATEGLUTAMIC ACIDVITAMIN B | 1 | Oral | 200 MG, UNK | 0 | 200 | MG | ||||||||
| 121136663 | 12113666 | 8 | C | CEREBREX | CALCIUM GLYCEROPHOSPHATECALCIUM PHOSPHATEGLUTAMIC ACIDVITAMIN B | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 121136663 | 12113666 | 1 | Relapsing-remitting multiple sclerosis |
| 121136663 | 12113666 | 2 | Product used for unknown indication |
| 121136663 | 12113666 | 3 | Product used for unknown indication |
| 121136663 | 12113666 | 4 | Product used for unknown indication |
| 121136663 | 12113666 | 5 | Pain prophylaxis |
| 121136663 | 12113666 | 6 | Prophylaxis |
| 121136663 | 12113666 | 7 | Pain prophylaxis |
| 121136663 | 12113666 | 8 | Prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 121136663 | 12113666 | HO |
| 121136663 | 12113666 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 121136663 | 12113666 | Inguinal hernia | |
| 121136663 | 12113666 | Liver function test increased | |
| 121136663 | 12113666 | Muscle spasms | |
| 121136663 | 12113666 | Pain | |
| 121136663 | 12113666 | Procedural pain | |
| 121136663 | 12113666 | Sepsis | |
| 121136663 | 12113666 | Spinal muscular atrophy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 121136663 | 12113666 | 1 | 20150327 | 201606 | 0 | |
| 121136663 | 12113666 | 5 | 2015 | 0 | ||
| 121136663 | 12113666 | 7 | 20160531 | 0 |